We sought to evaluate whether the clustering of multiple components of the metabolic syndrome (MS) has a greater impact on these vascular parameters than individual components of MS. BACKGROUND Intima-media thickness (IMT) and vascular stiffness have been shown to be independent predictors of adverse cardiovascular events. The MS is defined as the clustering of three or more of the cardiovascular risk factors of dysglycemia, hypertension, dyslipidemia, and obesity.
The metabolic syndrome (MS), also referred to as the insulin resistance syndrome, is defined as the clustering of several cardiovascular risk factors in an individual, including impaired glucose tolerance, hypertension, dyslipidemia, and abdominal obesity (1) (2) (3) . Epidemiologic studies have shown that MS is quite common, affecting 24% of the U.S. population between the ages of 20 and 70 years (4) . There is increasing evidence that this syndrome is a predictor of adverse cardiovascular events (4 -7) .
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The independent association between vascular structure and function and the individual components of MSnamely, hypertension (8 -12) , high-density lipoprotein (HDL) cholesterol (13) , triglycerides (8, 14) , waist circumference (9) , fasting glucose (14) , and hemoglobin A 1C (9)-has previously been reported.
Alterations in vascular structure and function, including increased arterial wall thickness, as indexed by intima-media thickness (IMT) and increased vascular wall stiffness, are also increasingly recognized as significant independent predictors of adverse cardiovascular outcomes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
We therefore undertook a cross-sectional study, using data from the Baltimore Longitudinal Study of Aging (BLSA), to examine the relationship between MS and large artery structure (thickness) and function (stiffness). We sought to evaluate whether the clustering of multiple components of MS has a greater impact on these vascular parameters than individual components of MS.
METHODS
Study population. The BLSA is a prospective study of community-dwelling volunteers, largely from the Baltimore/Washington area, conducted by the National Institute on Aging since 1958. The BLSA participants are healthy volunteers (age 21 to 96 years) who have agreed to return at regular intervals to the Gerontology Research Center in Baltimore, Maryland, for 2.5 days of medical, physiological, and psychological examinations (25) . Carotid ultrasonography was performed on a subset of the BLSA population chosen in a non-systematic yet random fashion. Of those, 471 subjects were free of preexisting coronary artery disease as defined by a history of angina pectoris, documented myocardial infarction, or major Q waves on the resting electrocardiogram (Minnesota Code 1:1 or 1:2) (26). Variables measured. BLOOD PRESSURE. Blood pressure (BP) determinations were performed in the morning, after a light breakfast, with subjects in the seated position, and after a quiet resting period of 5 min. Blood pressure was measured in both arms with a mercury sphygmomanometer using an appropriately sized cuff. The BP values used in this study are the average of the second and third measurements on both the right and left arms. Values for systolic blood pressure (SBP) and diastolic blood pressure (DBP) were defined by Korotkoff phases I and V, respectively. Pulse pressure was computed as PP ϭ (SBP Ϫ DBP); and mean BP was computed as MBP ϭ DBP ϩ (PP/3).
A total of 134 subjects (94 men and 40 women) were excluded because of concurrent antihypertensive therapy at the time of their first vascular measurement. These subjects were excluded because BP influences the values of the variables measured in the present study (8 -12) and because of the potential effects of specific antihypertensive drug classes on these parameters (27) (28) (29) (30) (31) . However, secondary analyses were performed, including treated hypertensive subjects, to exclude a potential hypertension selection bias.
ANTHROPOMETRY AND SMOKING STATUS. Height, weight, and waist circumference were determined for all participants. Body mass index was determined as kg/m 2 . Smoking status was ascertained by a questionnaire that classified each subject as a non-smoker, former smoker, or current smoker. For the purpose of the present study, "ever-smoker" status (former or current) was used.
PLASMA LIPIDS AND FASTING BLOOD GLUCOSE. Blood samples were drawn from the antecubital vein between 7 and 8 AM after an overnight fast. Subjects were not allowed to smoke, engage in significant physical activity, or take medications before the sample was collected. Concentrations of plasma triglycerides and total cholesterol were determined by an enzymatic method (Abott Laboratories ABA-200 ATC Biochromatic Analyzer, Irving, Texas). The concentration of HDL cholesterol was determined by a dextran sulfate-magnesium precipitation procedure (32 The fasting plasma glucose concentration was measured by the glucose oxidase method (Beckman Instruments, Inc., Fullerton, California). Carotid ultrasonography. High-resolution B-mode carotid ultrasonography was performed with a linear-array, 5-to 10-MHz transducer (Ultramark 9 HDI, Advanced Technology Laboratories, Inc., Seattle, Washington). The subject lay in the supine position in a dark, quiet room. Blood pressure was measured at 5-min intervals (Critikon 1846SX/P, version 085, Dinamap, Critikon, Tampa, Florida). The stabilized BP after 15 min from the onset of testing was used for subsequent analyses. The right common carotid artery (CCA) was examined with the head tilted slightly upward in the mid-line position. The transducer was manipulated so that the near and far walls of the CCA were parallel to the transducer footprint, and the lumen diameter was maximized in the longitudinal plane. A region 1.5 cm proximal to the carotid bifurcation was identified, and the IMT of the far wall was evaluated as the distance between the lumen-intima interface and the mediaadventitia interface. The IMT was measured on the frozen frame of a suitable longitudinal image, with the image magnified to achieve a higher resolution of detail. The IMT measurement was obtained from five contiguous sites at 1-mm intervals, and the average of the five measurements was used for analyses. All measurements were performed by a single sonographer. The intrarater correlation between repeated IMT measurements from 10 subjects was 0.96 (p Ͻ 0.001), with similar averages for the two sets of readings (0.47 Ϯ 0.13 vs. 0.45 Ϯ 0.12 mm, p ϭ NS) (33) .
Stiffness of the CCA was evaluated by the stiffness index (no unit) that has been validated by Kawasaki et To evaluate the independent determinants of IMT and stiffness, multiple regression models were constructed, which included age, gender, smoking, and each individual's risk factor component of MS (fasting glucose, SBP, DBP, triglycerides, HDL cholesterol, and waist circumference as continuous variables) as independent variables. A second set of models was constructed, which also included LDL as a co-variate. Both models yielded similar results; thus, only the latter set is presented subsequently. Stepwise regression analysis was used to calculate the contribution of the significant determinants of vascular indexes. To evaluate whether MS was independently associated with vascular stiffness and thickness, we ran the models again, after adding in MS as a dummy variable. To confirm the significance of MS, we constructed another set of models that included the individual components of MS (but without MS) as well as all of the possible interactions among these components. To illustrate the contribution of MS to the values of IMT and stiffness, these values were calculated with the least-squares method after adjusting for: 1) age and gender; 2) age, gender, and LDL; and 3) age, gender, LDL, smoking, and the individual components of MS. For each adjustment, the values were computed in the absence and in the presence of MS in the model, and they were compared by ANCOVA.
Logistic regression analysis was used to test whether MS was associated with a greater prevalence of outliers in carotid IMT, stiffness, or both after adjusting for age, gender, and each component of MS. Outliers were defined as values of IMT or stiffness that were in the highest quartile.
RESULTS
Our study population consisted of 471 subjects (200 men and 271 women; mean age 59 Ϯ 16 years) free of clinical overt cardiovascular disease at baseline. Table 1 shows the clinical characteristics of the study population. As expected, the values of all the anthropometric, metabolic, and BP variables were higher in patients with MS than in control subjects. Patients with MS were, on average, five years older (p Ͻ 0.01) and more likely to be men (52.6% vs. 39.9%, p Ͻ 0.05) than those without MS. No difference in the prevalence of current smokers was observed between the two groups. Carotid IMT was, on average, 16% higher, and stiffness was, on average, 32% higher in MS patients than in controls. Data are presented as the mean value Ϯ SD or percentage of subjects. BMI ϭ body mass index; DBP ϭ diastolic blood pressure; HDL ϭ high-density lipoprotein; IMT ϭ intima-media thickness; LDL ϭ low-density lipoprotein; MS ϭ metabolic syndrome; NS ϭ not significant; SBP ϭ systolic blood pressure. 
The prevalence of MS in this study population was 20.2%. Table 2 shows the prevalence of the individual components of MS by quartiles of age, as well as the prevalence of MS itself, defined as the clustering of three or more of these components. The prevalence of hypertension and MS increased with advancing age group quartiles, whereas a trend toward borderline statistical significance was observed for altered glucose homeostasis. Of note, alterations in HDL were more frequent than alterations in LDL in all age groups, which may be partly related to the levels used as cut-off values. The prevalence of elevated LDL increased with advancing age groups. Figure 1A shows that carotid IMT increased with advancing age quartiles in both MS patients and controls, and that in each age group, IMT was higher in MS patients than in controls. Figure 1B shows that CCA stiffness increased with advancing age quartiles in controls, and that in each group, stiffness was higher in MS patients than in controls. The interaction between age quartile and MS was not statistically significant, suggesting that the effects of MS on CCA thickness and stiffness do not significantly change across age groups. Effects of MS on CCA thickness and stiffness. Multiple regression models were constructed to evaluate the independent contributions of factors on carotid IMT and stiffness. A first set of models included age, gender, smoking, LDL, and each individual's component of MS, but excluded the variable of MS (i.e., clustering of MS components). As shown in Table 3 , age, male gender, LDL, and fasting blood glucose were each independently associated with IMT (model R 2 ϭ 0.406, p Ͻ 0.001). Age, fasting blood glucose, SBP, and DBP (negative coefficient) were each independently associated with stiffness (model R 2 ϭ 0.440, p Ͻ 0.001). When the first set of models was run again after adding MS as a dummy variable (second set), the variables remained independently associated with IMT and stiffness, respectively (Table 3) . However, MS was also found to be independently associated with both IMT (p ϭ 0.002) and stiffness (p ϭ 0.01) (Tables 3 and 4) , independent of the individual components of MS, which were also in the model, and accounting for 1.3% and 1.4% of the variability in IMT and stiffness, respectively.
Thus, the clustering of three or more of these components (i.e., MS) was independently associated with IMT or stiffness, even though several of the individual components of MS were not, suggesting that the clustering of these components interacted to exert synergistic effects on vascular structure and function. To explore this idea, an additional set of multiple regressions models were constructed for both IMT and stiffness. These models included age, gender, LDL, smoking, the individual components of MS, and interaction terms representing all of the possible interactions among these components as independent variables. For IMT and stiffness, we found that several terms representing the interaction of three or more components of MS were independently associated with these vascular parameters. This confirms that interactions among the individual components of MS exert synergistic effects on IMT and stiffness. Overall, the model R 2 (0.48 for both) was modestly increased by the addition of these interaction terms (R 2 ϭ 0.40 for IMT and R 2 ϭ 0.44 for stiffness in the absence of the interaction terms). This is likely due to the dominant effect of age in accounting for the variance in IMT and stiffness (ϳ35% for both).
To illustrate the contribution of MS to the values of IMT and stiffness, these values were calculated with the leastsquares method after adjusting for: 1) age and gender; 2) age, gender, and LDL; and 3) age, gender, LDL, smoking, and the individual components of MS (Table 5) . For each adjustment, the values were calculated in the absence and in the presence of MS in the model. By ANCOVA, the addition of MS to the models significantly increased the values of IMT and stiffness for all three adjustments. As noted earlier, the magnitude of the change attributed to MS was relatively small, because age was responsible for the largest part of the total variance. Log transformation of IMT yielded similar results. When treated and untreated hypertensive patients were combined, the significance of the same predictors persisted on multiple regression analyses, and the model R 2 were reduced by only 1%. These findings exclude a hypertension selection bias. Effects of MS on combined CCA thickness and stiffness. In unadjusted analyses, IMT and stiffness are significantly (p Ͻ 0.001), albeit weakly (R 2 ϭ 0.11), correlated with each other. We investigated whether MS was independently associated with simultaneous increases in the combined end point of carotid thickness and stiffness. Stiffness and IMT were divided into quartiles, and subjects were classified as outliers for each or both parameters if their values fell in the highest quartile of the parameters. As shown in Figure 2 , the MS group included a significantly greater percentage of subjects classified as outliers for either IMT or stiffness, compared with controls. Furthermore, the MS group included a significantly greater percentage of subjects classified as outliers for both IMT and stiffness, compared with controls. The increased risk of having excessive alterations in one or both of these vascular parameters remained significant even after adjusting for age, gender, and each individual's component of MS in a multivariable logistic The metabolic syndrome was defined according to the Adult Treatment Panel III criteria. All the models included age, gender, smoking, LDL cholesterol, and each individual's risk factor component of MS (fasting glucose, SBP, DBP, triglycerides, HDL cholesterol, and waist circumference as continuous variables) as independent variables. Only those variables that remained significant after backward stepwise elimination are shown in Tables 3 and 4 . Abbreviations as in Table 1 . 
DISCUSSION
The main findings of this study are that: 1) MS increases carotid arterial thickness and stiffness across all age groups; and 2) MS exerts its effects on carotid structure and function independent of its individual components and other cardiovascular risk factors. To our knowledge, only one previous study has investigated the relationship between MS and vascular stiffness. In studying a cohort of 180 non-diabetic, healthy, middle-aged women, van Popele et al. (36) found that carotid arterial distensibility was associated with several variables of MS, as well as with clustering of variables of MS, even after adjusting for mean BP. Our study confirms these findings and extends them insofar as: 1) we used a different index of stiffness that has been previously shown to be associated with insulin resistance in non-insulin-dependent diabetic subjects (37); 2) our study population included men and women; 3) was across a broad age range; and 4) showed that the association between MS and vascular stiffness was significant across all age groups. Furthermore, we found that MS, defined as the clustering of any three or more altered components, was itself an independent predictor of stiffness. Importantly, arterial stiffness is increasingly recognized as a potent and independent predictor of adverse cardiovascular outcomes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
The IMT increases with advancing age in humans (33) and in animal models of aging (38, 39) . In this study, we found that MS was associated with higher vascular wall thickness, compared with controls, across all age groups. A few previous studies have evaluated the association between MS and IMT (40 -42) . In a cross-sectional populationbased study in Sweden, Hedblad et al. (40) found that ageand gender-adjusted IMT was significantly higher in MS patients than in controls. Hulthe et al. (41) studied clinically healthy 58-year-old men. They found that patients with MS had a significantly higher common carotid, carotid bulb, and femoral IMT than did subjects without risk factors. On the other hand, they did not find any significant differences in these IMT variables between MS patients and those with only one risk factor. Of note, they used the World Health Organization (2) definition of MS, which uses components and cut-off values for defining alterations in these components that are somewhat different from those of the ATP III.
A novel finding of our study is that MS conferred increased odds of having both thicker and stiffer large arteries. In fact, a significantly greater percentage of subjects with extremely high IMT and stiffness was observed in the MS group than in the control group.
There is increasing interest in the relevance of multiple risk factors, as well as the existence of thresholds in the relationships between the levels of known risk factors and the risk of disease (42) (43) (44) . The presence of a dose-response relation between the levels of known risk factors and the risk of cardiovascular disease, whether measured by incident cardiovascular event or "intermediate phenotypes" such as subclinical vascular disease, indicates that there is value in modifying risk factors in people at high risk, irrespective of the reason for the high risk and regardless of the level of the risk factor. Potential mechanisms. It is conceivable that one of the mechanisms by which MS exerts its well-documented deleterious effects is by adversely affecting the structural and functional properties of the vasculature (such as thickness and stiffness). Interestingly, MS was associated with a higher prevalence of alterations in both vascular parameters. Alternatively, it is possible that a common pathogenic factor could underlie both the arterial structural changes and the alterations in the components that comprise MS.
Circumferential wall stress and flow-mediated shear stress are considered to be important determinants of arterial wall structure and function during development and their remodeling during aging or in response to disease in adults (45) (46) (47) (48) (49) . Blood pressure and blood flow are major determinants of these mechanical stresses that act on the arterial wall and lumen. Of note, we have previously demonstrated that in the context of an increased circumferential wall stress, specific alterations in carotid geometry were associated with differing levels of flow-mediated shear stress and resulted in specific patterns of alterations in carotid function (50) .
Another potential mechanism by which MS can alter large-artery structure and function might be the glycation of matrix proteins. Alterations in matrix proteins within the vessel wall can be derived from nonenzymatic cross-links between glucose (or other reducing sugars) and amino groups that generate advanced glycation end products (AGEPs) (51, 52) . The AGEPs accumulate slowly on longlived proteins, such as collagen and elastin, and lead to increased stiffening of both arteries and the heart (51). In animal models, decreasing these cross-links enhances vascular and cardiac compliance (53) (54) (55) (56) . Of note, we recently showed in a randomized, double-blinded, placebocontrolled study that a novel medication that cleaves the AGEPs cross-links favorably impacts measures of vascular stiffness in older human subjects (57) . Study limitations. Certain limitations of this study should be recognized, including its cross-sectional nature. Longitudinal observations are required in order to more fully address the relationships and potential mechanistic links between MS and vascular structure and function. Furthermore, the study population is relatively small, predominantly Caucasian and well educated, which limits the generalizability of our findings, even though the prevalence of MS in our study was similar to that observed by others (58) . Future studies that include more racially and socioeconomically diverse populations are needed to further investigate the relationship between MS and vascular structure and function.
An additional limitation is that the BP values used to calculate the carotid stiffness index were measured over the brachial artery, which tends to overestimate carotid pressures due to central to peripheral BP amplification (59) . Central (carotid) BPs measured on the same visit as the carotid Doppler studies were available for 26 subjects. As anticipated, brachial SBP (116 Ϯ 14 mm Hg) exceeded central SBP (103 Ϯ 14 mm Hg). However, the correlation between central and brachial measurements of ln (SBP/ DBP), the numerator of the stiffness index, was 0.92. These findings suggest a fixed difference in ln (SBP/DBP), which should lead to a fixed, systematic error in the stiffness index. Conclusions. Our analyses indicate that MS is independently associated with increased thickness and stiffness of the carotid artery. Because increased arterial stiffness and thickness are well established as age-associated processes, this suggests that MS can be perceived as accelerating vascular aging. The excess alteration in carotid structure and function conferred by MS over and above the risk associated with abnormalities in each single component of this syndrome raises the prospect that integrated preventive or therapeutic strategies that target multiple components of MS may yield synergistically improved outcomes, as compared with those that are aimed at the individual components.
Future studies should investigate the mechanistic links between MS and vascular aging, and whether strategies to reduce vascular stiffness or thickness can attenuate the deleterious outcomes of MS.
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